Insmed Other Non Cash Items vs Free Cash Flow Analysis
INSM Stock | USD 23.60 0.56 2.32% |
Insmed financial indicator trend analysis is infinitely more than just investigating Insmed Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Insmed Inc is a good investment. Please check the relationship between Insmed Other Non Cash Items and its Free Cash Flow accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
Other Non Cash Items vs Free Cash Flow
Other Non Cash Items vs Free Cash Flow Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Insmed Inc Other Non Cash Items account and Free Cash Flow. At this time, the significance of the direction appears to have pay attention.
The correlation between Insmed's Other Non Cash Items and Free Cash Flow is -0.82. Overlapping area represents the amount of variation of Other Non Cash Items that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of Insmed Inc, assuming nothing else is changed. The correlation between historical values of Insmed's Other Non Cash Items and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Non Cash Items of Insmed Inc are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of Other Non Cash Items i.e., Insmed's Other Non Cash Items and Free Cash Flow go up and down completely randomly.
Correlation Coefficient | -0.82 |
Relationship Direction | Negative |
Relationship Strength | Significant |
Other Non Cash Items
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Most indicators from Insmed's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Insmed Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. At this time, Insmed's Selling General Administrative is very stable compared to the past year. As of the 26th of May 2024, Tax Provision is likely to grow to about 2.7 M, while Issuance Of Capital Stock is likely to drop about 250.4 M.
Insmed fundamental ratios Correlations
Click cells to compare fundamentals
Insmed Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Insmed fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 742.3M | 796.2M | 1.2B | 1.7B | 1.3B | 1.4B | |
Other Current Liab | 280K | 63.4M | 89.2M | 131.7M | 215.0M | 225.7M | |
Total Current Liabilities | 85.2M | 118.8M | 135.2M | 190.2M | 225.6M | 236.9M | |
Total Stockholder Equity | 261.7M | 275.9M | 410.5M | 88.0M | (331.9M) | (315.3M) | |
Property Plant And Equipment Net | 113.1M | 97.2M | 95.5M | 102.1M | 104.4M | 109.6M | |
Net Debt | (90.4M) | (127.9M) | (104.5M) | 103.8M | 721.6M | 757.7M | |
Retained Earnings | (1.5B) | (1.8B) | (2.3B) | (2.7B) | (3.4B) | (3.3B) | |
Accounts Payable | 13.2M | 42.9M | 35.8M | 50.5M | 65.4M | 68.7M | |
Cash | 487.4M | 532.8M | 716.8M | 1.1B | 482.4M | 506.5M | |
Non Current Assets Total | 187.1M | 173.3M | 406.5M | 383.1M | 400.8M | 420.8M | |
Non Currrent Assets Other | 20.3M | 26.8M | 51.0M | 76.1M | 96.6M | 101.4M | |
Cash And Short Term Investments | 487.4M | 532.8M | 716.8M | 1.1B | 780.4M | 819.5M | |
Common Stock Total Equity | 897K | 1.0M | 1.2M | 1.4M | 1.6M | 804.3K | |
Common Stock Shares Outstanding | 84.6M | 97.6M | 112.1M | 123.0M | 140.4M | 147.5M | |
Liabilities And Stockholders Equity | 742.3M | 796.2M | 1.2B | 1.7B | 1.3B | 1.4B | |
Other Current Assets | 20.2M | 24.0M | 28.9M | 25.5M | 24.2M | 25.4M | |
Other Stockholder Equity | 1.8B | 2.1B | 2.7B | 2.8B | 3.1B | 3.3B | |
Total Liab | 480.6M | 520.3M | 833.0M | 1.6B | 1.7B | 1.7B | |
Property Plant And Equipment Gross | 113.1M | 97.2M | 95.5M | 102.1M | 149.0M | 156.5M | |
Total Current Assets | 555.2M | 622.9M | 837.0M | 1.3B | 929.1M | 975.5M | |
Accumulated Other Comprehensive Income | (10K) | 193K | 968K | 756K | (745K) | (782.3K) | |
Common Stock | 897K | 1.0M | 1.2M | 1.4M | 1.5M | 837.2K | |
Other Assets | 72.5M | 70.0M | 51.0M | 113.7M | 130.7M | 137.3M | |
Good Will | 58.7M | 53.7M | 49.3M | 136.1M | 156.5M | 164.4M | |
Non Current Liabilities Total | 395.4M | 401.5M | 697.9M | 1.4B | 1.4B | 1.5B | |
Intangible Assets | 53.7M | 49.3M | 73.8M | 68.8M | 63.7M | 61.3M | |
Property Plant Equipment | 60.2M | 54.0M | 53.0M | 56.5M | 65.0M | 68.2M | |
Net Receivables | 19.2M | 16.6M | 24.4M | 29.7M | 41.2M | 43.2M | |
Short Long Term Debt Total | 397.0M | 404.8M | 612.3M | 1.2B | 1.2B | 1.3B | |
Long Term Debt | 335.9M | 356.3M | 566.6M | 1.1B | 1.2B | 1.2B | |
Inventory | 28.3M | 49.6M | 67.0M | 69.9M | 83.2M | 87.4M | |
Net Tangible Assets | 208.0M | 226.6M | 200.5M | (116.9M) | (134.5M) | (127.7M) | |
Retained Earnings Total Equity | (1.5B) | (1.8B) | (2.3B) | (2.7B) | (2.4B) | (2.3B) | |
Capital Surpluse | 1.8B | 2.1B | 2.7B | 2.8B | 3.2B | 3.4B | |
Deferred Long Term Liab | 52.1M | 47.3M | 72.0M | 37.6M | 43.2M | 45.7M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Insmed Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Insmed Stock analysis
When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.23) | Revenue Per Share 2.199 | Quarterly Revenue Growth 0.158 | Return On Assets (0.32) | Return On Equity (14.53) |
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.